IN8Bio Competitors and Similar CompaniesClear all
IN8Bio's competitors and similar companies include Aura Biosciences.
 IN8Bio IN8Bio (formerly known as Innatus Therapeutics, Incysus Therapeutics) is a clinical-stage biopharmaceutical company focused on the development of gamma-delta T cell therapies for the treatment of cancer. |  Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. | |
Founding Date | Founding Date 2016 | Founding Date 2009 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ Birmingham, US | Locations Cambridge, US HQ |
Employees | Employees 13 | Employees 42 |
Valuation ($) | Valuation ($) 19.9 m | Valuation ($) 544.2 m |
Financial | ||
Net income | Net income ($19.4m) (FY, 2025) | Net income ($106.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 35m | Total funding raised $ 213.9m |
For sources of this data, please see the company profile
View Company Profiles
Aura Biosciences
HQ
Cambridge, US
Employees
42
Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology.
View company